Showing results (301-310 of 1,645) with videos related to
Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|May 2, 2018
Investigation of the Study Characteristics Affecting Clinical Trial Quality Using the Protocol Deviations Leading to Exclusion of Subjects From the Per Protocol Set Data in Studies for New Drug Application: A Retrospective AnalysisNorihito Kohara, Masayuki Kaneko, Mamoru NarukawaTherapeutic Innovation & Regulatory Science|May 2, 2018
Use of Proxy Variables to Determine the Impact of Protocol Complexity on Clinical Research Site ProductivityDavid J MorinTherapeutic Innovation & Regulatory Science|May 2, 2018
Comparison of Brief Summary Formats Through a Health Literacy LensMichele L Sharp, Lori Hall, Anthony Eleftherion, et al.Therapeutic Innovation & Regulatory Science|May 2, 2018
Unresectable and Metastatic Melanoma of the Skin: Literature Review of Clinical Trials and Efficacy Endpoints Since 2000Susan Jin, Pallavi S Mishra-Kalyani, Rajeshwari SridharaTherapeutic Innovation & Regulatory Science|May 2, 2018
Industry and Patient Perspectives on Child Participation in Clinical Trials: The Pediatric Assent Initiative Survey ReportDonald Lombardi, Liza Squires, Philip Sjostedt, et al.Therapeutic Innovation & Regulatory Science|May 2, 2018
Medical Science Liaisons in Real-World Evidence Studies: Experience of AstraZeneca RussiaNikolay Suvorov, Vera Karaseva, Ekaterina Stukalina, et al.Therapeutic Innovation & Regulatory Science|May 2, 2018
Medical Writing Competency Model - Section 2: Knowledge, Skills, Abilities, and BehaviorsDavid B Clemow, Bertil Wagner, Christopher Marshallsay, et al.Therapeutic Innovation & Regulatory Science|May 2, 2018
Principles and Methods of Statistical Assessment of Abuse-Deterrent OpioidsLing ChenTherapeutic Innovation & Regulatory Science|August 29, 2018
European Pharma Oligonucleotide Consortium: A Move to Consolidate Oligonucleotide Knowledge and Share Experience Within the CommunityAnna Tivesten, Nadim Akhtar, Jessica Stolee, et al.Therapeutic Innovation & Regulatory Science|June 19, 2018
How 4 Companies Became One: Co-development Under an Outsourced Model With Focus on Phase 3 Analysis and Reporting DeliverablesSusan Huyck, Gregory Golm, Sajda Ghani, et al.Pageof 165